A practical critique of antifungal treatment guidelines for haemato-oncologists

Samir Agrawal; Brian Jones; Rosemary Barnes; Chris Kibbler; Mike Millen; Mary Ashcroft; Sarjana Jain; Anna Last; David Lewis; Tom Lewis; Mitul Patel; Antonio Pagliuca

doi:10.3109/1040841X.2011.645521

A practical critique of antifungal treatment guidelines for haemato-oncologists

Samir Agrawal^*, Brian Jones, Rosemary Barnes, Chris Kibbler, Mike Millen, Mary Ashcroft, Sarjana Jain, Anna Last, David Lewis, Tom Lewis, Mitul Patel, Antonio Pagliuca

^*Corresponding author for this work

Research output: Contribution to journal › Literature review › peer-review

10 Citations (Scopus)

Abstract

The management of invasive fungal disease (IFD) in the haemato-oncology setting remains a challenge. This article reviews recent guidelines relating to IFD for their similarities and differences, as well as applying the Appraisal of Guidelines Research and Evaluation (AGREE) criteria. The guidelines' recommendations on antifungal prophylaxis, empirical and definitive treatment of candidiasis and aspergillosis are summarized; also, minimum standards for diagnosis and follow-up are discussed. This critique of the reviewed guidelines is a practical guide to physicians and commissioners in making local policies for IFD management.

Original language	English
Pages (from-to)	203-216
Number of pages	14
Journal	Critical Reviews in Microbiology
Volume	38
Issue number	3
DOIs	https://doi.org/10.3109/1040841X.2011.645521
Publication status	Published - Aug 2012

Keywords

Fungal infection
AGREE
Candida aspergillus
haematological oncology
INVASIVE FUNGAL-INFECTIONS
CLINICAL-PRACTICE GUIDELINES
DISEASES-WORKING-PARTY
HIGH-RISK
GERMAN-SOCIETY
CELL TRANSPLANTATION
NEUTROPENIC PATIENTS
CONTROLLED-TRIAL
THERAPY
HEMATOLOGY

Access to Document

10.3109/1040841X.2011.645521

Cite this

@article{04b3f9459e8f4aec9b9e26e2c681d0ad,

title = "A practical critique of antifungal treatment guidelines for haemato-oncologists",

abstract = "The management of invasive fungal disease (IFD) in the haemato-oncology setting remains a challenge. This article reviews recent guidelines relating to IFD for their similarities and differences, as well as applying the Appraisal of Guidelines Research and Evaluation (AGREE) criteria. The guidelines' recommendations on antifungal prophylaxis, empirical and definitive treatment of candidiasis and aspergillosis are summarized; also, minimum standards for diagnosis and follow-up are discussed. This critique of the reviewed guidelines is a practical guide to physicians and commissioners in making local policies for IFD management.",

keywords = "Fungal infection, AGREE, Candida aspergillus, haematological oncology, INVASIVE FUNGAL-INFECTIONS, CLINICAL-PRACTICE GUIDELINES, DISEASES-WORKING-PARTY, HIGH-RISK, GERMAN-SOCIETY, CELL TRANSPLANTATION, NEUTROPENIC PATIENTS, CONTROLLED-TRIAL, THERAPY, HEMATOLOGY",

author = "Samir Agrawal and Brian Jones and Rosemary Barnes and Chris Kibbler and Mike Millen and Mary Ashcroft and Sarjana Jain and Anna Last and David Lewis and Tom Lewis and Mitul Patel and Antonio Pagliuca",

year = "2012",

month = aug,

doi = "10.3109/1040841X.2011.645521",

language = "English",

volume = "38",

pages = "203--216",

journal = "Critical Reviews in Microbiology",

issn = "1040-841X",

publisher = "Informa Healthcare",

number = "3",

}

TY - JOUR

T1 - A practical critique of antifungal treatment guidelines for haemato-oncologists

AU - Agrawal, Samir

AU - Jones, Brian

AU - Barnes, Rosemary

AU - Kibbler, Chris

AU - Millen, Mike

AU - Ashcroft, Mary

AU - Jain, Sarjana

AU - Last, Anna

AU - Lewis, David

AU - Lewis, Tom

AU - Patel, Mitul

AU - Pagliuca, Antonio

PY - 2012/8

Y1 - 2012/8

N2 - The management of invasive fungal disease (IFD) in the haemato-oncology setting remains a challenge. This article reviews recent guidelines relating to IFD for their similarities and differences, as well as applying the Appraisal of Guidelines Research and Evaluation (AGREE) criteria. The guidelines' recommendations on antifungal prophylaxis, empirical and definitive treatment of candidiasis and aspergillosis are summarized; also, minimum standards for diagnosis and follow-up are discussed. This critique of the reviewed guidelines is a practical guide to physicians and commissioners in making local policies for IFD management.

AB - The management of invasive fungal disease (IFD) in the haemato-oncology setting remains a challenge. This article reviews recent guidelines relating to IFD for their similarities and differences, as well as applying the Appraisal of Guidelines Research and Evaluation (AGREE) criteria. The guidelines' recommendations on antifungal prophylaxis, empirical and definitive treatment of candidiasis and aspergillosis are summarized; also, minimum standards for diagnosis and follow-up are discussed. This critique of the reviewed guidelines is a practical guide to physicians and commissioners in making local policies for IFD management.

KW - Fungal infection

KW - AGREE

KW - Candida aspergillus

KW - haematological oncology

KW - INVASIVE FUNGAL-INFECTIONS

KW - CLINICAL-PRACTICE GUIDELINES

KW - DISEASES-WORKING-PARTY

KW - HIGH-RISK

KW - GERMAN-SOCIETY

KW - CELL TRANSPLANTATION

KW - NEUTROPENIC PATIENTS

KW - CONTROLLED-TRIAL

KW - THERAPY

KW - HEMATOLOGY

U2 - 10.3109/1040841X.2011.645521

DO - 10.3109/1040841X.2011.645521

M3 - Literature review

SN - 1040-841X

VL - 38

SP - 203

EP - 216

JO - Critical Reviews in Microbiology

JF - Critical Reviews in Microbiology

IS - 3

ER -

A practical critique of antifungal treatment guidelines for haemato-oncologists

Abstract

Keywords

Access to Document

Fingerprint

Cite this